Dr. Johnston's holdings have seen fluctuations over the years, reflecting his approach to stock options and performance-based incentives. As of 2023, he emphasized cash compensation, having not vested any stock in recent years. His focus has shifted away from stock...

Dr. Johnston's holdings have seen fluctuations over the years, reflecting his approach to stock options and performance-based incentives. As of 2023, he emphasized cash compensation, having not vested any stock in recent years. His focus has shifted away from stock options towards managing Exponent's operational success. This strategy highlights his alignment with the company's long-term goals rather than short-term stock price movements. Historical records show that in 2018, he had a peak compensation of over $2.4 million, reflecting the company's strong performance that year. Since then, there has been a significant change in his compensation structure, steering clear from stock reliance. His holdings strategy demonstrates a personal commitment to the company's sustained operational health rather than speculative gains.